Literature DB >> 30003471

Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases.

Kazuchika Nishitsuji1,2.   

Abstract

Highly sulfated domains of heparan sulfate (HS), also known as HS S-domains, consist of repeated trisulfated disaccharide units [iduronic acid (2S)-glucosamine (NS, 6S)-]. The expression of HS S-domains at the cell surface is determined by two mechanisms: tightly regulated biosynthetic machinery and enzymatic remodeling by extracellular endoglucosamine 6-sulfatases, Sulf-1 and Sulf-2. Intracellular or extracellular deposits of misfolded and aggregated proteins are characteristic of protein aggregation diseases. Although proteins can aggregate alone, deposits of protein aggregates in vivo contain a number of proteinaceous and non-protein components. HS S-domains are one non-protein component of these aggregated deposits. HS S-domains are considered to be critical for signal transduction of several growth factors and several disease conditions, such as tumor progression, but their roles in protein aggregation diseases are not yet fully understood. This review summarizes the current understanding of the possible roles of HS S-domains and Sulfs in the formation and cytotoxicity of protein aggregates.

Entities:  

Keywords:  Amyloid; Amyloidosis; Glycosaminoglycan; Heparan sulfate; Protein aggregation disease; Sulf; Sulfatase

Mesh:

Substances:

Year:  2018        PMID: 30003471     DOI: 10.1007/s10719-018-9833-8

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  112 in total

Review 1.  Neurovascular mechanisms of Alzheimer's neurodegeneration.

Authors:  Berislav V Zlokovic
Journal:  Trends Neurosci       Date:  2005-04       Impact factor: 13.837

2.  Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.

Authors:  Robert W Mahley; Yadong Huang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  Basement membrane proteoglycans: from cellar to ceiling.

Authors:  Renato V Iozzo
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

4.  The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis.

Authors:  I D Young; J P Willmer; R Kisilevsky
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  X-ray diffraction studies on amyloid filaments.

Authors:  E D Eanes; G G Glenner
Journal:  J Histochem Cytochem       Date:  1968-11       Impact factor: 2.479

Review 6.  Glypican-1 facilitates prion conversion in lipid rafts.

Authors:  Nigel M Hooper
Journal:  J Neurochem       Date:  2011-03       Impact factor: 5.372

7.  Heparin inhibits membrane interactions and lipid-induced fibrillation of a prion amyloidogenic determinant.

Authors:  Ehud Bazar; Tania Sheynis; Jerzy Dorosz; Raz Jelinek
Journal:  Chembiochem       Date:  2011-02-18       Impact factor: 3.164

8.  Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.

Authors:  I-Hsuan Liu; Vladimir N Uversky; Larissa A Munishkina; Anthony L Fink; Willi Halfter; Gregory J Cole
Journal:  Glycobiology       Date:  2005-07-21       Impact factor: 4.313

9.  Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

Authors:  R Kisilevsky; L J Lemieux; P E Fraser; X Kong; P G Hultin; W A Szarek
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

10.  Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.

Authors:  Kathleen A Burke; Elizabeth A Yates; Justin Legleiter
Journal:  Front Neurol       Date:  2013-03-01       Impact factor: 4.003

View more
  6 in total

1.  Targeting the Extracellular Matrix Promotes Healing Following Myocardial Infarction.

Authors:  Thomas N Wight; Robert B Vernon
Journal:  Circ Res       Date:  2019-10-10       Impact factor: 17.367

2.  Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.

Authors:  Naoyuki Iwahashi; Midori Ikezaki; Taro Nishikawa; Norihiro Namba; Takashi Ohgita; Hiroyuki Saito; Yoshito Ihara; Toshinori Shimanouchi; Kazuhiko Ino; Kenji Uchimura; Kazuchika Nishitsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

Review 3.  Sulfation pathways from red to green.

Authors:  Süleyman Günal; Rebecca Hardman; Stanislav Kopriva; Jonathan Wolf Mueller
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

4.  Cell-to-cell transmission of p53 aggregates: a novel player in oncology?

Authors:  Naoyuki Iwahashi; Midori Ikezaki; Hiroyuki Saito; Kenji Uchimura; Kazuchika Nishitsuji
Journal:  Mol Cell Oncol       Date:  2021-03-22

5.  Analysis of circulating protein aggregates as a route of investigation into neurodegenerative disorders.

Authors:  Rocco Adiutori; Fabiola Puentes; Michael Bremang; Vittoria Lombardi; Irene Zubiri; Emanuela Leoni; Johan Aarum; Denise Sheer; Simon McArthur; Ian Pike; Andrea Malaspina
Journal:  Brain Commun       Date:  2021-07-09

6.  HS and Inflammation: A Potential Playground for the Sulfs?

Authors:  Rana El Masri; Yoann Crétinon; Evelyne Gout; Romain R Vivès
Journal:  Front Immunol       Date:  2020-04-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.